跳至主要内容
临床试验/IRCT20201219049763N1
IRCT20201219049763N1招募中3 期

A clinical trial to assess the effectiveness of antiemetic and anti-halitosis topical peppermint cream and orally ingestible peppermint oxymel mouthwash in breast cancer patients during chemotherapy

Iranian academic center for education culture and research0 个研究点目标入组 225 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
225

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • No history of nausea and vomiting for other reasons
  • Full consciousness
  • Complete satisfaction in participating in this project
  • Breast cancer, ac4T4 chemotherapy regimen, taking anti-nausea and vomiting drugs Aprepitant and Dexamethasone
  • No history of allergies Medicinal plants
  • No history of respiratory diseases, asthma, diabetes and autoimmune diseases

排除标准

  • Eliminate patients who use medications or treatments other than those prescribed during the study to reduce nausea and vomiting
  • Patients who forget to use the product and mouthwash three or more times in a row

研究者

发起方
Iranian academic center for education culture and research

相似试验